|
gptkbp:instanceOf
|
gptkb:company
|
|
gptkbp:acquiredBy
|
gptkb:Advanced_Liquid_Logic
gptkb:BlueGnome
gptkb:Edico_Genome
gptkb:Epicentre_Biotechnologies
gptkb:Grail
gptkb:Helixis
gptkb:Verinata_Health
|
|
gptkbp:CEO
|
gptkb:Francis_deSouza
gptkb:Jacob_Thaysen
|
|
gptkbp:competitor
|
gptkb:Pacific_Biosciences
gptkb:Oxford_Nanopore_Technologies
gptkb:Thermo_Fisher_Scientific
|
|
gptkbp:focus
|
biomedical research
personalized medicine
genomics research
genetic sequencing
|
|
gptkbp:founded
|
1998
|
|
gptkbp:founder
|
gptkb:Anthony_A._Czarnik
gptkb:Anthony_Czarnik
gptkb:John_Stuelpnagel
gptkb:Larry_Bock
gptkb:Mark_Chee
gptkb:David_Walt
|
|
gptkbp:headquartersLocation
|
gptkb:San_Diego,_California,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Illumina
|
|
gptkbp:industry
|
gptkb:biotechnology
genomics
|
|
gptkbp:listedOn
|
gptkb:NASDAQ
|
|
gptkbp:marketCap
|
over $30 billion (2023)
|
|
gptkbp:notableProduct
|
gptkb:HiSeq
gptkb:MiSeq
gptkb:NextSeq
gptkb:NovaSeq
gptkb:iSeq
|
|
gptkbp:numberOfEmployees
|
~9,100 (2022)
|
|
gptkbp:parentCompany
|
gptkb:public_company
|
|
gptkbp:product
|
DNA sequencers
Genotyping kits
Microarrays
Next-generation sequencing platforms
|
|
gptkbp:regulatoryIssue
|
EU antitrust investigation
FTC blocked Grail acquisition
|
|
gptkbp:revenue
|
$4.5 billion (2022)
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:stockExchange
|
gptkb:NASDAQ
|
|
gptkbp:stockSymbol
|
gptkb:ILMN
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
https://www.illumina.com/
|
|
gptkbp:bfsParent
|
gptkb:John_W._Thompson
|
|
gptkbp:bfsLayer
|
4
|